InvestorsHub Logo
Followers 0
Posts 1200
Boards Moderated 0
Alias Born 05/05/2017

Re: FDApproved post# 17970

Tuesday, 11/06/2018 9:45:33 AM

Tuesday, November 06, 2018 9:45:33 AM

Post# of 44784
Place this gently in your DD pipe...

The Company will also present at the BioEurope, Annual Vascular Interventional Advances and Cell and Gene Therapy Manufacturing conferences, all held in November
HAIFA, Israel, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc.(PSTI) (PSTI.TA), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced that the Company will be presenting at four conferences during November: at the BioEurope conference, which is being held November 5–7, 2018 in Copenhagen, at the 15th Annual Vascular Interventional Advances (VIVA) Conference, which is being held November 5-8 in Las Vegas, at the 2018 American Heart Association (AHA) Scientific Sessions, which are being held November 10-12 in Chicago and the Cell and Gene Therapy Manufacturing conference, which is being held November 14-15 in London.